Pricing Log in Create free account

Anebulo Pharmaceuticals, Inc. (ANEB) vs Radiopharm Theranostics Limited - Sponsored ADR (RADX)

Anebulo Pharmaceuticals, Inc. and Radiopharm Theranostics Limited - Sponsored ADR are both Biotechnology companies. Anebulo Pharmaceuticals, Inc. and Radiopharm Theranostics Limited - Sponsored ADR are of similar size ($17.6M and $17.0M). Across the 5 metrics below, Radiopharm Theranostics Limited - Sponsored ADR leads on 3 and Anebulo Pharmaceuticals, Inc. on 2.

Valuation

Metric ANEB RADX Biotechnology median
P/E n/m — 8.50
P/S n/m — 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 1.03 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield 0.00% — (33.15%)
Free cash flow yield 0.00% 0.00% (25.50%)

Profitability

Metric ANEB RADX Biotechnology median
Gross margin — — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (69.69%) 0.00% (56.36%)
Return on assets (63.17%) 0.00% (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANEB RADX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 21.88% (1.97%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ANEB RADX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 6.24 1.16 4.72
Net debt to EBITDA 1.32 0.08 0.96

Dividend

Metric ANEB RADX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANEB RADX Biotechnology median
Market cap 17.60m 16.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack